Dopamine agonists for restless legs syndrome
Restless Legs Syndrome (RLS) is a common neurological disorder characterised by an uncontrollable urge to move the legs. Dopamine agonists are widely used as first or second-line treatments for RLS due to their efficiency in alleviating the symptoms of RLS and improving sleep quality. Whilst efficac...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Whitehouse Publishing
2025-02-01
|
| Series: | Advances in Clinical Neuroscience & Rehabilitation |
| Online Access: | https://acnr.co.uk/articles/dopamine-agonists-for-restless-legs-syndrome/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832086498633056256 |
|---|---|
| author | Pran Phakdeekitcharoen Michael J Keogh |
| author_facet | Pran Phakdeekitcharoen Michael J Keogh |
| author_sort | Pran Phakdeekitcharoen |
| collection | DOAJ |
| description | Restless Legs Syndrome (RLS) is a common neurological disorder characterised by an uncontrollable urge to move the legs. Dopamine agonists are widely used as first or second-line treatments for RLS due to their efficiency in alleviating the symptoms of RLS and improving sleep quality. Whilst efficacious, dopamine agonists can also cause several side effects which are important to understand and monitor. This article aims to provide a practical overview of when and how to prescribe dopamine agonists together with appropriate monitoring advice for clinicians. |
| format | Article |
| id | doaj-art-4acdb3a4cc1e40d3b16c658ee18bab4c |
| institution | Kabale University |
| issn | 1473-9348 2397-267X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Whitehouse Publishing |
| record_format | Article |
| series | Advances in Clinical Neuroscience & Rehabilitation |
| spelling | doaj-art-4acdb3a4cc1e40d3b16c658ee18bab4c2025-02-06T14:27:05ZengWhitehouse PublishingAdvances in Clinical Neuroscience & Rehabilitation1473-93482397-267X2025-02-0110.47795/DHJD7994Dopamine agonists for restless legs syndrome Pran Phakdeekitcharoen0Michael J Keogh1Newcastle Upon Tyne Hospitals NHS Foundation Trust, UK.Newcastle Health Innovation Partners, UK.Restless Legs Syndrome (RLS) is a common neurological disorder characterised by an uncontrollable urge to move the legs. Dopamine agonists are widely used as first or second-line treatments for RLS due to their efficiency in alleviating the symptoms of RLS and improving sleep quality. Whilst efficacious, dopamine agonists can also cause several side effects which are important to understand and monitor. This article aims to provide a practical overview of when and how to prescribe dopamine agonists together with appropriate monitoring advice for clinicians.https://acnr.co.uk/articles/dopamine-agonists-for-restless-legs-syndrome/ |
| spellingShingle | Pran Phakdeekitcharoen Michael J Keogh Dopamine agonists for restless legs syndrome Advances in Clinical Neuroscience & Rehabilitation |
| title | Dopamine agonists for restless legs syndrome |
| title_full | Dopamine agonists for restless legs syndrome |
| title_fullStr | Dopamine agonists for restless legs syndrome |
| title_full_unstemmed | Dopamine agonists for restless legs syndrome |
| title_short | Dopamine agonists for restless legs syndrome |
| title_sort | dopamine agonists for restless legs syndrome |
| url | https://acnr.co.uk/articles/dopamine-agonists-for-restless-legs-syndrome/ |
| work_keys_str_mv | AT pranphakdeekitcharoen dopamineagonistsforrestlesslegssyndrome AT michaeljkeogh dopamineagonistsforrestlesslegssyndrome |